Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
about
Cotrimoxazole - optimal dosing in the critically ill.A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapySingle dose pharmacokinetics of trimethoprimPharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactionsMultiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers.Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patientsPharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjectsOptimization of anti-infective dosing regimens during online haemodiafiltrationPharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.Suboptimal Cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
P2860
Q33652427-D6B20DBB-C9E3-4F43-9F6A-EB9159BFEF91Q33751794-F2280004-8DAA-4E46-B5BC-74D4DFD822F9Q35601605-BC963B91-9E90-4427-AD3B-712E681000F5Q35640897-62E982DF-B1EB-4B6C-8AFD-CE5D2333702CQ35690237-C67C47E9-1D0E-4A43-BC59-4DEFD829C38FQ35810094-33BB1F27-AD69-45A1-8A09-20C253779B2BQ36754721-923A6A46-9C2F-46B4-9423-0160F2020D6DQ36754937-5F2F7CE9-6895-4A0E-BFE5-57EE23ACE149Q38843412-338434F1-2F29-46C6-8F37-9497E7F3CEBFQ39778838-D27AFA9B-1A4A-49C6-9232-771BE8B7EEBEQ40097078-ABFF5DF9-3775-4717-924A-AD2B3C7DD3D3Q47689257-71CD2606-76A9-41AE-ACC4-05CCD419A7E5
P2860
Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
description
1982 nî lūn-bûn
@nan
1982 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մարտին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Pharmacokinetics of intravenou ...... l and impaired renal function.
@ast
Pharmacokinetics of intravenou ...... l and impaired renal function.
@en
type
label
Pharmacokinetics of intravenou ...... l and impaired renal function.
@ast
Pharmacokinetics of intravenou ...... l and impaired renal function.
@en
prefLabel
Pharmacokinetics of intravenou ...... l and impaired renal function.
@ast
Pharmacokinetics of intravenou ...... l and impaired renal function.
@en
P2093
P1476
Pharmacokinetics of intravenou ...... l and impaired renal function.
@en
P2093
P304
P577
1982-03-01T00:00:00Z